Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Arcturus, Beigene, Can-Fite, Celltrion, Diffusion, Generex, Genor, Inotrem, Kyowa Kirin, Mesoblast, Neoimmunetech, Redhill.